You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 15, April 16, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bioequivalence of Levothyroxine Preparations: Industry Sponsorship and Academic Freedom-Reply

Betty J. Dong, PharmD; John G. Gambertoglio, PharmD; Lauren Gee, MPH; Francis S. Greenspan, MD
University of California, San Francisco

Walter W. Hauck, PhD
Thomas Jefferson University Philadelphia, Pa

John R. White
Washington State University Spokane

Jeff L. Bubp
San Mateo County General Hospital San Mateo, Calif

JAMA. 1997;277(15):1200-1201.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We appreciate the comments by Mr Eckert to clarify and defend Knoll's action to date, although some of the study chronology is in error. We are delighted at the prospect of finally being able to publish our findings. We have tried our best to cooperate with Knoll even though we believed their concerns to be unjustified. We found it impossible to comply with many of their requests because to do so would have intentionally altered our study findings.

We are pleased that Knoll now recognizes the importance of academic freedom, the peer review process, and the need to allow scientific debate to occur.

This unfortunate incident has illuminated the fragile relationship that could exist between a sponsor and investigators when the results of a study are not as anticipated. The difficult, sobering, and painful lessons learned should be remembered by all when collaborations between industry and academia occur. We know . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.